Abstract
A characteristic behavioral syndrome has been associated with stimulation of central serotonin receptors in rats. This behavior can be produced by inhibition of monoamine oxidase and administration of 5-hydroxytryptophan as well as by direct acting serotonergic agonists. LSD and the novel ergot derivative lisuirde produced this syndrome in rats. These drugs possess both serotonergic and dopaminergic properties. Since changes in dopaminergic function have also been reported to affect the so-called serotonin syndrome, it was not clear how the two ergot drugs acted to produce this syndrome. The syndrome produced by pargyline and 5-hydroxytryptophan methyl ester was blocked by haloperidol, methysergide, parachlorophenylalanine, and alpha-methylparatyrosine; these treatments failed to block the effects of lisuride. Metoclopramide did not block the syndrome produced by either lisuride or pargyline plus 5-hydroxytryptophan methyl ester. Methysergide partially blocked the behavioral effects of LSD; pretreatment with either haloperidol or metoclopramide potentiated and prolonged the behavioral effects of LSD. The results suggest that dopaminergic modulation of the serotonin syndrome occurs before the serotonin receptor involved in this behavior. Also, the differences between LSD and lisuride may be relevant to their different psychopharmacological properties.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Da Prada, M., Bonetti, E. P., Keller, H. H.: Induction of mounting behavior in female and male rats by lisuride. Neurosci. Letters 6, 349–353 (1977)
Foldes, A., Costa, E.: Relationship of brain monoamine and locomotor activity in rats. Biochem. Pharmacol. 24, 1617–1621 (1975)
Grahame-Smith, D. C.: Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18, 1053–1066 (1971)
Green, A. R., Grahame-Smith, D. G.: The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology 13, 949–959 (1974)
Green, A. R., Grahame-Smith, D. G.: Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 260,487–491 (1976)
Haigler, H., Aghajanian, G. K.: Peripheral serotonin antagonists: Failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J. Neural. Transm. 35, 257–273 (1974)
Hollister, A. S., Breese, G. R., Kuhn, C. M., Cooper, B. R., Schanburg, S. M.: An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine. J. Pharmacol. Exp. Ther. 198, 12–22 (1976)
Horowski, R., Wachtel, H.: Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice. Eur. J. Pharmacol. 36, 373–383 (1976)
Jacobs, B. L.: Evidence for the functional interaction of two central neurotransmitters. Psychopharmacology 39, 81–86 (1974)
Jacobs, B. L.: An animal behavior model for studying central serotonergic synapses. Life Sci. 19, 777–786 (1976)
Jacobs, B. L., Eubanks, E. E., Wise, W. D.: Effect of indolealkylamine manipulations on locomotor activity in rats. Neuropharmacology 13, 575–583 (1974)
Kehr, W.: Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain. Eur. J. Pharmacol. 41, 261–273 (1977)
Kehr, W., Speckenbach, W.: Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain. Naunyn Schmiedebergs. Arch. Pharmacol. 301, 163–169 (1978)
Pieri, L., Keller, H. H., Burkard, W., Da Prada, M.: Effects of lisuride and LSD on cerebral monoamines systems and hallocinosis. Nature 272, 278–280 (1978)
Silbergeld, E. K., Hruska, R. E., Weir, R., Kennedy, S. W.: In: Dopaminergic ergot derivatives and motor function. K. Fuxe, D. B. Calne, eds., pp. 223–235, Oxford: Pergamon 1979
Simon, P., Pueche, A. J., Chermat, R., Boissier, J. R.: Stereotyped behavior induced in rats by apomorphine and amphetamine. An approach to better utilization. In: Neuropsychopharmacology, J. R. Boissier, H. Hippius, P. Pichet, eds., pp. 517–523 New York Elsevier 1975
Sloviter, R. S., Drust, E. G., Connor, J. D.: Specificity of a rat behavioral model for serotonin receptor activation. J. Pharmacol. Exp. Ther. 206, 339–347 (1978)
Sofia, R. E., Vassar, H. B.: The effect of ergotamine and methysergide on serotonin metabolism in the rat brain. Arch. Int. Pharmacodyn. Ther. 216, 40–50 (1975)
Trulson, M. E., Ross, C. A., Jacobs, B. L.: Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD. Psychopharmacol. Commun. 2, 149–164 (1976)
Walters, J. R., Baring, M. D., Lakoski, J. M.: Effects of ergolines on dopaminergic and serotonergic single unit activity. In Dopaminergic ergot derivatives and motor function. K. Fuxe, D. B. Calne, eds., pp. 207–221 Oxford: Pergamon 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silbergeld, E.K., Hruska, R.E. Lisuride and LSD: Dopaminergic and serotonergic interactions in the “serotonin syndrome”. Psychopharmacology 65, 233–237 (1979). https://doi.org/10.1007/BF00492209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00492209